drugset
drugset / Trial / NCT01937338

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

NCT01937338 ↗

Phase 1 Completed 60 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

Study to investigate the effect of a single dose of AZD7624 on inflammation caused by an endotoxin challenge.

Timeline

Start
2013-10
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7624 Small molecule 20 mg/ml Inhaled

Indications

No indication recorded.